Drug Type Small molecule drug |
Synonyms 亮晶晶, 双朗, 圣元 + [9] |
Action antagonists, stimulants, agonists |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists), MUT stimulants(Methylmalonyl-CoA Mutase stimulants), α-adrenergic receptor agonists(Alpha adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date China (01 Jan 1997), |
Regulation- |
Molecular FormulaC63H88CoN14O14P |
InChIKeyDLRXOSFAWIKARM-SYUKHSAKSA-M |
CAS Registry68-19-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Eye Diseases | China | 01 Jan 1997 |